In phase I trials, which objective is typically sought?

Prepare for the CPHON Chemotherapy Test with interactive materials. Use flashcards and multiple choice questions with hints and explanations. Get exam-ready!

Multiple Choice

In phase I trials, which objective is typically sought?

Explanation:
In Phase I trials the main goal is to establish safety and figure out the highest dose that can be given without unacceptable toxicity. This is done by identifying dose-limiting toxicities (DLTs) and determining the maximum tolerated dose (MTD) through dose-escalation in small patient cohorts. Pharmacokinetics and pharmacodynamics are studied to understand how the drug behaves in the body and to guide dosing, but efficacy against disease is not the primary objective at this stage. Early signals of activity can occur, yet a Phase I trial is not designed to compare efficacy to standard treatments.

In Phase I trials the main goal is to establish safety and figure out the highest dose that can be given without unacceptable toxicity. This is done by identifying dose-limiting toxicities (DLTs) and determining the maximum tolerated dose (MTD) through dose-escalation in small patient cohorts. Pharmacokinetics and pharmacodynamics are studied to understand how the drug behaves in the body and to guide dosing, but efficacy against disease is not the primary objective at this stage. Early signals of activity can occur, yet a Phase I trial is not designed to compare efficacy to standard treatments.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy